Vignot S - Search Results

1

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority.

Vignot S, Dhanani A, Sainte-Marie I, de Ligniville Lajavardi L, Even G, Echemann M, Hulin N, Ménoret C, Maison P, Ratignier-Carbonneil C. Vignot S, et al. Front Pharmacol. 2022 Aug 15;13:972660. doi: 10.3389/fphar.2022.972660. eCollection 2022. Front Pharmacol. 2022. PMID: 36046816 Free PMC article.

2

Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé).

Vignot S, Daynes P, Bacon T, Vial T, Montagne O, Albin N, Emmerich J, Ratignier-Carbonneil C, Martin D, Maison P. Vignot S, et al. Front Pharmacol. 2021 Apr 28;12:635841. doi: 10.3389/fphar.2021.635841. eCollection 2021. Front Pharmacol. 2021. PMID: 33995037 Free PMC article. No abstract available.

3

[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].

Vignot S, Le Blaye O, Fluckiger L, Errard S, Marin B, Chapel E. Vignot S, et al. Bull Cancer. 2020 Jun;107(6):617-619. doi: 10.1016/j.bulcan.2020.04.007. Epub 2020 May 7. Bull Cancer. 2020. PMID: 32414537 Free PMC article. French. No abstract available.

4

Facilitating access to new therapeutic options through clinical trials: the vision of a regulator to reconcile innovation and safety.

Vignot S, Martin M, Albin N, Schurtz C, Chapel E. Vignot S, et al. Ann Oncol. 2019 Nov 1;30(11):1694-1696. doi: 10.1093/annonc/mdz389. Ann Oncol. 2019. PMID: 31501860 Free article. No abstract available.

5

[New prescription modalities for nominative premarket access: Tailored for infectiology].

Vignot S, Blaise T, Martin M. Vignot S, et al. Med Mal Infect. 2020 Jun;50(4):386-387. doi: 10.1016/j.medmal.2019.10.013. Epub 2019 Nov 14. Med Mal Infect. 2020. PMID: 31733934 French. No abstract available.

6

[New prescription procedures for authorisations for temporary use: A key step for access to innovation].

Vignot S, Chapel E. Vignot S, et al. Bull Cancer. 2019 Nov;106(11):943-945. doi: 10.1016/j.bulcan.2019.07.009. Epub 2019 Sep 25. Bull Cancer. 2019. PMID: 31563270 French. No abstract available.

7

New modalities of prescription of ATUns: Evolutions and revolution.

Vignot S, Plaine G, Chapel E. Vignot S, et al. Rev Neurol (Paris). 2020 May;176(4):290-292. doi: 10.1016/j.neurol.2019.07.023. Epub 2019 Oct 11. Rev Neurol (Paris). 2020. PMID: 31611006 No abstract available.

8

[American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].

Vignot S, Bay JO, Blay JY, Gonçalves A, Massard C, Thariat J, Wislez M, André T. Vignot S, et al. Bull Cancer. 2011 Dec;98(12):1509-23. doi: 10.1684/bdc.2011.1510. Bull Cancer. 2011. PMID: 22182714 French.

9

[Hot topics about early clinical trials at ASCO congress 2018: News pathways, new targets, new associations].

Auvray M, Baylot C, Blanc-Durand F, Borcoman E, Pons-Tostivint E, Vignot S. Auvray M, et al. Among authors: vignot s. Bull Cancer. 2018 Nov;105(11):1084-1093. doi: 10.1016/j.bulcan.2018.08.010. Epub 2018 Oct 16. Bull Cancer. 2018. PMID: 30340752 Review. French.

10

[EGFR-targeted therapies: what's new?].

Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters